Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis

Mariapaola Marino, Mario Sabatelli, Giovambattista Pani, Amelia Evoli, Flavia Scuderi, Daniela Maria Samengo, Emanuela Bartoccioni, Giorgia Saltelli, Chengyong Shen, Lin Mei, Giovanni Antonini

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

22 Citazioni (Scopus)

Abstract

Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients have autoantibodies against the muscle nicotinic acetylcholine receptor (AChR), while autoantibodies to muscle-specific tyrosine kinase (MuSK) have been detected in half (5%) of the remaining 10%. Recently, the low-density lipoprotein receptor-related protein 4 (LRP4), identified as the agrin receptor, has been recognized as a third autoimmune target in a significant portion of the double sero-negative (dSN) myasthenic individuals, with variable frequency depending on different methods and origin countries of the tested population. There is also convincing experimental evidence that anti-LRP4 autoantibodies may cause MG.
Lingua originaleEnglish
pagine (da-a)e0135378-e0135378
RivistaPLoS One
Volume10
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • autoantibody
  • autoimmunity

Fingerprint Entra nei temi di ricerca di 'Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis'. Insieme formano una fingerprint unica.

Cita questo